[vc_row content_width="grid" disable_margin_on_row="no"][vc_column][vc_column_text] Carlina Technologies Signs A Partnership Agreement With Atlangram To Develop Controlled-Release Forms Of Antibiotics Targeting Osteoarticular Diseases [/vc_column_text][vc_column_text]2/16/2014 9:52:27 AM[/vc_column_text][vc_column_text]Angers, France, December 16, 2014 - CARLINA Technologies, a biotechnology company specializing in the development of nanomedicines, today announces the signing of a partnership agreement with Atlangram...